Not applicableStudy completedNCT02104518What this trial is testingEvaluation of Different G6PD Testing PlatformsWho this might be right forGlucose-6-Phosphate Dehydrogenase Deficiency PATH 700
Not applicableStudy completedNCT02857023What this trial is testingFeasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell DiseaseWho this might be right forAnemia, Sickle Cell Steven J. Hardy 91
Not applicableStudy completedNCT02207218What this trial is testingTo Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in JapanWho this might be right forCongenital Bleeding DisorderHaemophilia A Novo Nordisk A/S 40
Not applicableUnknownNCT02433782What this trial is testingMyofascial Therapy in Patients With Hemophilic ArthropathyWho this might be right forHemophilia Universidad Católica San Antonio de Murcia 25
Not applicableStudy completedNCT04772391What this trial is testingFitness Trial in Adults With Sickle Cell Disease (SCD Fit): A Feasibility StudyWho this might be right forCardiovascular DiseasesSickle Cell DiseaseExercise Memorial Healthcare System 10
Post-approval studies (Phase 4)Study completedNCT00243542What this trial is testingPhase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD DeficiencyWho this might be right forAcne Vulgaris Allergan 64
Testing effectiveness (Phase 2)Ended earlyNCT00773890What this trial is testingTRF-1101 Assessment in Sickle Cell DiseaseWho this might be right forSickle Cell Disease TRF Pharma, Inc 80
Large-scale testing (Phase 3)Study completedNCT00182390What this trial is testingPremature Infants in Need of Transfusion (PINT)Who this might be right forAnemia of Prematurity McMaster University 424
Post-approval studies (Phase 4)Study completedNCT04985682What this trial is testingADVATE in People With Hemophilia A in IndiaWho this might be right forHemophilia A Baxalta now part of Shire 50
Testing effectiveness (Phase 2)Looking for participantsNCT06546670What this trial is testingA Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell DiseaseWho this might be right forSickle Cell Disease Novartis Pharmaceuticals 161
Early research (Phase 1)Study completedNCT00087204What this trial is testingRebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous LeukemiaWho this might be right forAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+13 more National Cancer Institute (NCI) 40
Large-scale testing (Phase 3)Study completedNCT06153784What this trial is testingThalidomide and Hydroxyurea Combination in β-Thalassemia PatientsWho this might be right forThalassemia, Beta Children's Hospital Karachi 603
Large-scale testing (Phase 3)Study completedNCT00006400What this trial is testingHydroxyurea to Prevent Organ Damage in Children With Sickle Cell AnemiaWho this might be right forHematologic DiseasesAnemia, Sickle Cell National Heart, Lung, and Blood Institute (NHLBI) 193
Early research (Phase 1)Study completedNCT03935633What this trial is testingShort-term Clinical Study of CN128 in Thalassemia PatientsWho this might be right forThalassemia Hangzhou Zede Pharma-Tech Co., Ltd. 16
Not applicableStudy completedNCT03876301What this trial is testingLead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A ParticipantsWho this might be right forBlood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more Spark Therapeutics, Inc. 25
Not applicableLooking for participantsNCT07418099What this trial is testingExternal Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform AnalysisWho this might be right forCoagulation Disorder, BloodProlonged APTT Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 1,500
Large-scale testing (Phase 3)Looking for participantsNCT06003387What this trial is testingEfficacy and Safety of CSL222 (Etranacogene Dezaparvovec) Gene Therapy in Adults With Hemophilia B With Pretreatment Adeno-associated Virus Serotype 5 (AAV5) Neutralizing Antibodies (Nabs)Who this might be right forHemophilia B CSL Behring 35
Not applicableEnded earlyNCT00651716What this trial is testingT Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell TransplantWho this might be right forBreast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more Vanderbilt-Ingram Cancer Center 150
Testing effectiveness (Phase 2)Study completedNCT00739388What this trial is testingAzacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyWho this might be right forLeukemia Swiss Cancer Institute 47
Early research (Phase 1)Study completedNCT00001399What this trial is testingGene Therapy for the Treatment of Fanconi's Anemia Type CWho this might be right forFanconi's AnemiaPancytopenia National Heart, Lung, and Blood Institute (NHLBI) 9